Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Pionyr on the sale. Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena) and Pionyr Immunotherapeutics, Inc. have announced the closing of Ikena’s acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Oaktree on the financing. Harrow (Nasdaq: HROW) announced that it has entered into a $100 million secured credit financing agreement with funds...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Lindsay Goldberg in the transaction. MMS Holdings Inc. (MMS), a leading data-focused contract research organization (CRO), has announced that Lindsay Goldberg, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented TPG Capital in the transaction. Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has...
You must be a Standard 1 Year member to access this content.
Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
You must be a Standard 1 Year member to access this content.
